AKT1 and obstructive sleep apnea syndrome: In contrast, our investigation provides deeper insights, revealing that the anti‐OSA effects of silencing SQLE were achieved through depleting cholesterol and subsequently inhibiting the FAK/PI3K/Akt/mTOR signalling pathway.